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In experimental autoimmune glomerulonephritis
(EAG), a model of Goodpasture’s disease, Wistar
Kyoto (WKY) rats immunized with collagenase-solu-
bilized glomerular basement membrane (GBM) or the
recombinant NC1 domain of the 3 chain of type IV
collagen [3(IV)NC1] develop anti-GBM antibodies
and focal necrotizing glomerulonephritis with cres-
cent formation. However, Lewis (LEW) rats, which
share the same major histocompatibility complex
(MHC) haplotype, are resistant to EAG development.
A genome-wide linkage analysis of backcrossed ani-
mals with EAG revealed a major quantitative trait lo-
cus (QTL) on rat chromosome 13 (LOD  3.9) linked
to the percentage of glomerular crescents. To investi-
gate the role of this QTL in EAG induction, reciprocal
congenic rats were generated (LEW.WCrgn1 congenic
and WKY.LCrgn1 congenic), immunized with recom-
binant rat 3(IV)NC1, and assessed for EAG develop-
ment. WKY.LCrgn1 rats showed a marked reduction
in albuminuria, severity of crescentic nephritis, and
number of glomerular macrophages compared with
WKY controls. No reduction in antibody levels was
observed. However, LEW.WCrgn1 rats were resistant
to EAG development, as were LEW controls. Macro-
phage activation in vitro was assessed in parental and
congenic rat bone marrow–derived macrophages
(BMDMs). WKY.LCrgn1 BMDMs showed a significant
reduction in Fc receptor–mediated oxidative burst,
phagocytosis of opsonised polystyrene beads, and
LPS-induced levels of MCP-1 secretion and iNOSmRNA expression compared with WKY rats. These
results confirm the importance of Crgn1 on chromo-
some 13 in EAG susceptibility, mediated partly
through differences in Fc receptor-mediated macro-
phage activation. (Am J Pathol 2012, 180:1843–1851; DOI:
10.1016/j.ajpath.2012.01.029)
Goodpasture’s, or anti-glomerular basement membrane
(GBM), disease is an autoimmune disorder characterized
by rapidly progressive glomerulonephritis and lung hem-
orrhage.1 The disease is caused by autoantibodies to
basement membranes of glomeruli and alveoli,2 and
the pathogenicity of human antibodies has been dem-
onstrated in passive transfer studies in primates.3 The
autoantigen has been identified as the the noncollag-
enous domain of the 3 chain of type IV collagen
[3(IV)NC1],4,5 and the major epitope involved has been
localized to the amino terminal of the 3(IV)NC1 mole-
cule.6–8 Goodpasture’s disease is associated with cer-
tain major histocompatibility complex (MHC) class II al-
leles; in particular, a positive association has been shown
with DR15 and DR4 and a negative association with DR7
and DR1.9,10 T cells from patients with Goodpasture’s
disease proliferate in response to the Goodpasture anti-
gen,11 and it has been shown that the precursor frequency
of autoreactive T cells specific for 3(IV)NC1 is higher in
patients with active disease than in controls and declines
following treatment.12 The disease relapses extremely
rarely, perhaps due to the influence of CD4CD25 regu-
latory T cells.13
Experimental autoimmune glomerulonephritis (EAG),
an animal model of Goodpasture’s disease, can be in-
duced in Wistar Kyoto (WKY) rats by immunization with
collagenase-solubilized glomerular basement membrane
(GBM),14–18 or the noncollagenous domain of the 3
chain of type IV collagen [3(IV)NC1].19–21 This model of
EAG in the WKY rat is characterized by anti-GBM anti-
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nied by focal necrotizing glomerulonephritis with cres-
cent formation. In contrast, when Lewis (LEW) rats, which
share the same MHC background as WKY rats (Rt1-l),
are immunized with GBM or 3(IV)NC1, they are resistant
to the development of crescentic nephritis.22 Interest-
ingly, when LEW rats are immunized with whole GBM,
they develop circulating anti-GBM antibodies, but these
do not recognize 3(IV)NC1.23
In previous studies examining the genetic basis of
susceptibility to EAG, we found that first-generation
crosses (F1; WKY  LEW) were completely resistant to
the development of EAG, whereas WKY backcross ani-
mals (BC1; WKY  F1) showed a range of responses,
from severe crescentic glomerulonephritis to no histolog-
ical evidence of disease.22 These results indicate that
EAG is inherited as a complex trait, with a role for WKY
genes not linked to the MHC. In parallel studies, a full
genome screen has been performed in a different model
of glomerulonephritis, nephrotoxic nephritis (NTN), in
WKY rats.24 This study, using second-generation crosses
(F2; F1  F1), revealed two major quantitative trait loci
(QTLs) on chromosomes 13 and 16 (designated crescen-
tic glomerulonephritis 1 [Crgn1] and 2 [Crgn2]), both of
which were linked to crescent formation and proteinuria.
Infiltration of macrophages was also strongly linked to
Crgn1. Several biological candidates were found in the
Crgn1 region of linkage, including genes encoding the
activatory Fc receptor for IgG Fcgr3 (also known as
FcRIII), the inhibitory Fc receptor Fcgr2 (FcRII), and the
common -subunit Fcer1g (FcR). It was shown that copy
number polymorphism of Fcgr3 accounted for the predis-
position to glomerulonephritis in the WKY strain at Crgn1.24
In further work focusing on the Crgn2 locus on chromo-
some 16 and its effect on NTN-related phenotypes in the
WKY rat, the AP-1 transcription factor Jundwas shown to be
a determinant of macrophage activation.25 Reciprocal con-
genic rats were generated by introgressing LEWCrgn2 onto
aWKY genetic background (WKY.LCrgn2) and WKY Crgn2
onto a LEW background (LEW.WCrgn2). WKY.LCrgn2
rats showed significantly reduced glomerular crescent
formation, fibrin deposition, and macrophage infiltration,
whereas LEW.WCrgn2 rats showed significantly more
proteinuria and macrophage infiltration than the respec-
tive background strains, demonstrating that the Crgn2
linkage region influences NTN susceptibility.25 Further-
more, it was shown that Crgn2 regulates macrophage
activation; for example, bone marrow–derived macro-
phages (BMDMs) from WKY.LCrgn2 rats showed re-
duced Fc receptor–mediated macrophage activation,
and diminished expression of the inducible nitric oxide
synthase gene (Nos2) on lipopolysaccharide (LPS) stim-
ulation.25
In this study, we report for the first time a major quan-
titative trait locus (QTL) on chromosome 13 (LOD  3.9)
linked to glomerular crescent formation in WKY rats with
EAG. Transferring the chromosome 13 QTL region iden-
tified in NTN from LEW rats to WKY rats (WKY.LCrgn1
congenic) resulted in a marked reduction in susceptibility
to EAG, and BMDMs from these congenic animals
showed reduced Fc receptor–mediated macrophage ac-tivation, phagocytosis, and LPS-induced levels of MCP-1
secretion and iNOS mRNA expression. These results
demonstrate the importance of the chromosome 13 QTL
in susceptibility to EAG and should lead to insights into
pathogenetic mechanisms, which may be applicable to
human glomerulonephritis.
Materials and Methods
Experimental Animals
Male and female Wistar-Kyoto (WKY/NCr1BR) rats (RT1-l)
were purchased from Charles River (Margate, UK), and
male and female Lewis (LEW/SsNHsd) rats (RT1-l) were
purchased from Harlan UK (Bicester, UK). All animals
were housed in standard conditions and had free access
to normal laboratory diet and water. All experimental pro-
cedures were conducted in accordance with the UK An-
imals (Scientific Procedures) Act.
Generation of Backcross Animals
First-generation intercross (F1) progeny were produced
by the mating of WKY with LEW rats, and backcross
progeny (BC1, n  196) were produced by crossing the
F1 population with the WKY parental strain.
Generation of Congenic Animals
Congenic rat lines were produced by introgression of the
QTL region on chromosome 13, Crgn1 (D13Rat86–
D13Rat51) from the WKY donor onto the LEW recipient
genome and vice versa. Crgn1 congenics on both
WKY (WKY.LEW-D13Arb15-D13Rat58, designated as
WKY.LCrgn1), and LEW (LEW.WKY-D13Arb15-D13Rat58,
designated as LEW.WCrgn1), genetic backgrounds were
generated by backcrossing the (WKY  LEW) F1 rats to
WKY and LEW parental strains for nine generations. Rats
heterozygous for the chromosome-13 linkage region
were brother–sister mated to fix the congenic interval and
obtain the congenic lines.26
Production of Rat GBM
Collagenase-solubilized rat GBM (csGBM) was prepared
from Sprague Dawley (SD) rat kidneys, as previously
described.17,18 Briefly, the kidneys were decapsulated,
the medulla partly removed, and the cortex passed
through a series of sieves to isolate the glomeruli. After
examination by light microscopy, the glomeruli were dis-
rupted ultrasonically, and the resulting material lyophilized
and digested with purified type I collagenase (Sigma-
Aldrich, Poole, UK) for 1 hour at 37°C.
Production of Recombinant Rat 3(IV)NC1
Recombinant rat 3(IV)NC1 (generated from cDNA en-
coding the full-length of 3(IV)NC1 from SD rats) was
produced from a stably transfected HEK293 cell line, as
previously described.20,21 Purification of recombinant rat
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ity chromatography using an anti-FLAG M2 affinity col-
umn (Sigma-Aldrich, Poole, UK), Recombinant rat
3(IV)NC1 was then characterized by Western blotting,
using serum from an animal with EAG and control serum,
as previously described.21
Induction of EAG in BC1 Animals
Male and female WKY (n  5), LEW (n  5) and BC1 rats
(n  196), aged 6 to 8 weeks and weighing 120 to 150 g,
were given a single intramuscular injection of rat GBM in
an equal volume of Freund’s complete adjuvant (FCA;
Sigma-Aldrich) at a dose of 5 mg/kg body weight.17,18 All
animals were sacrificed at day 28 after immunization.
Induction of EAG in Congenic Animals
Female WKY (n  6), LEW (n  6), WKY/LCrgn1(n  7),
and LEW/WCrgn1 (n  7) rats, aged 6 to 8 weeks and
weighing 120 to 150g, were given a single intramuscular
injection of recombinant rat 3(IV)NC1 in an equal vol-
ume of FCA (Sigma-Aldrich Company Ltd.) at a dose of
100 g/rat.20,21 All animals were sacrificed at day 28 after
immunization.
Assessment of EAG in BC1 and Congenic
Animals
Albumin Excretion
Urinary albumin concentrations were measured in 24-
hour collections from experimental animals at day 28 by
rocket immunoelectrophoresis (Amersham Bioscience
UK Ltd.), as previously described.17,18 Briefly, urine sam-
ples from experimental animals were subjected to immu-
noelectrophoresis at 60 v in an electrophoresis tank con-
taining Barbitone buffer (BDH Laboratory Supplies,
Poole, Dorset, UK), pH 9.5, for 6 h, using a 1% agarose
gel (BDH Laboratory Supplies) containing rabbit anti-
sera to rat albumin raised in our laboratory. Results were
calculated using rat serum albumin standards (which
were run at the same time) and expressed in milligrams
per 24 hours.
Light Microscopy
Kidney tissue was fixed in 10% neutral buffered forma-
lin, processed, and embedded in paraffin wax for light
microscopy. Briefly, 3-m sections were stained with he-
motoxylin and eosin, and periodic acid-Schiff. Fifty glom-
eruli per section were assessed by a blinded observer
(HTC) and the severity of the crescentic nephritis graded
as: crescents affecting more than 50% of circumference
of the glomerulus, crescents affecting less than 50% of
circumference of the glomerulus, or normal, and ex-
pressed as a percentage of glomeruli examined.17,18Immunohistochemistry
Macrophage numbers were assessed in formalin-
fixed, paraffin-embedded kidney sections stained with
mouse monoclonal antibody ED1 (Serotec Ltd., Kidling-
ton, UK), followed by biotinylated goat anti-mouse IgG
secondary antibody (Dako Ltd., Cambridge, UK), and an
avidin-biotin complex (Dako Ltd.). The cellular infiltrate
was quantified by counting the number of positively
stained cells per 50 consecutive glomeruli in cross sec-
tion.18,21
ELISA
Circulating antibody concentrations to 3(IV)NC1
were measured in sera of experimental animals at day
28 after immunization by a direct solid-phase enzyme-
linked immunosorbent assay (ELISA), as previously de-
scribed.20,21 Briefly, recombinant rat 3(IV)NC1 was
coated on to microtiter ELISA plates (Life Technologies,
Paisley, UK) at a concentration of 5 g/mL by overnight
incubation at 4°C. Sera from experimental animals were
applied at a predetermined optimum dilution of 1/100 for
1 hour at 37°C. Bound anti-3(IV)NC1 antibody was de-
tected by alkaline phosphatase–conjugated sheep anti-
rat IgG (Sigma-Aldrich.), and developed using the sub-
strate p-nitrophenyl phosphate (NPP, Sigma-Aldrich).
The absorbencies for each well were read at 405 nm
using an Anthos Multiskan ELISA plate reader (Lab Tech
International, Uckfield, UK), and results were calculated
as mean optical density for each triplicate sample.
Direct Immunofluorescence
Deposits of IgG within the glomeruli were detected by
direct immunofluorescence, as previously described.17,28
Kidney tissue was embedded in OCT II embedding me-
dium (Miles Inc., Elkhart, IN) on cork disks, snap frozen in
isopentane (BDH Laboratory Supplies) precooled in liq-
uid nitrogen, and stored at 80°C. Cryostat sections
were cut at 5 m and were incubated with fluorescein
isothiocyanate (FITC)–labeled rabbit anti-rat IgG (Serotec
Ltd.). The degree of IgG deposition was assessed by a
blinded observer (J.R.), by grading the intensity of immu-
nostaining from 0 to 3 per 50 consecutive glomeruli in
cross-section.
Genetic Mapping in the Backcross Population
Genomic DNA was extracted from the spleens of WKY,
LEW, F1, and BC1 animals using the Genomix DNA ex-
traction kit (VH BIO Ltd, Gosforth, UK), as previously
described.22 Microsatellite primers spanning the full rat
genome, and within 20 cM of each other, were obtained
from Genosys Biotechnology (Cambridge, UK). PCR am-
plifications were performed using a TouchDown subam-
bient thermal cycler (Hybaid). In the first instance, mic-
rosatellite genotyping was performed on parental strain
and F1 DNA to confirm published polymorphisms and to
derive a panel of polymorphic microsatellites for this
strain combination (WKY v LEW). PCR products were
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Elmer, Cambridge, UK) and scored on an ABI 377 auto-
mated sequencer (Perkin Elmer), using the GeneScan
program (Perkin Elmer). BC1 progeny were genotyped
as homozygous (WKY/WKY) or heterozygous (WKY/LEW)
at each individual microsatellite marker.22
Bone Marrow–Derived Macrophages
Bone marrow–derived macrophages (BMDM) from WKY,
LEW, and WKY.LCrgn1 congenic rats were isolated, as
previously described.25,26 Femurs were excised and
washed in 70% ethanol, sterile PBS, and Hanks’ bal-
anced salt solution (HBSS) (Sigma-Aldrich). Bones were
transferred to a fresh Petri dish, where both ends were
snapped and the bone marrow flushed out with 510 mL
of Hank medium. Cells were washed three times with
Hank medium, then resuspended in 20 mL of DMEM
supplemented with 100 U/mL penicillin, 100 g/mL strep-
tomycin, 20% FCS, 25% L929 medium, and cultured at
37°C in a total volume of 25 mL in 140-mm tissue culture
Petri dishes (Corning, Ithaca, NY). On day 3 of culture,
nonadherent cells were carefully removed and fresh ster-
ile culture medium was added. Macrophages were har-
vested on day 5 by washing with sterile PBS and incu-
bation with 5 mL cell dissociation buffer (Sigma-Aldrich)
at 37°C for 10 minutes.
Fc-Mediated Oxygen Burst Activity
BMDM from WKY, LEW, and WKY.LCrgn1 congenic rats
were assessed by Fc OxyBURST to investigate Fc-medi-
ated function.25,26 Briefly, cells (1  106 macrophages)
were harvested and resuspended in Krebs-Ringer PBS
(KRP buffer) with 1.0 mmol/L Ca2, 1.5 mmol/L Mg2,
and 5.5 mmol/L glucose, warmed to 37°C for 10 minutes,
then stimulated with the Fc OxyBURST immune complex
(120 g/mL; Invitrogen). Fc OxyBURST–induced oxida-
tive burst was assessed at different time points using flow
cytometry to measure the percentage of fluorescent cells
on a FACScalibur (BD Biosciences), analyzed using Cell-
quest software (BD Biosciences).
Phagocytosis Assay
BMDM from WKY, LEW, and WKY.LCrgn1 congenic rats
were assessed for phagocytosis.24,25 Latex polystyrene
6.0-m microspheres (20 or 50 beads/macrophage;
Polysciences Inc.) were incubated in 10 mg/mL BSA
(Sigma-Aldrich) in PBS overnight at 4°C. The beads were
then washed 3 times in PBS and resuspended in 100 l
of PBS. Rabbit anti-bovine albumin IgG fraction (Sigma-
Aldrich), was added to a final dilution of 1:2 and incu-
bated for 1 hour at room temperature. The beads were
then washed three times in 1 mL of PBS and used imme-
diately. Macrophages were cultured as described above
and plated in eight-well glass chamber slides at 105
cells/well. Medium was changed to serum-free medium
for 2 hours before adding the beads. Opsonized beads
(20 or 50 beads/macrophage) were added to macro-
phages and incubated at 37°C in 5% CO2 for 30 minutes.The medium was then aspirated, and slides were stained
with Diff-Quick fix (Dade Behring). One hundred macro-
phages were counted to determine the number of beads
ingested per cell.
Monocyte Chemotactic Protein–1 Determination
by ELISA
The level of monocyte chemotactic protein–1 (MCP-1)
cytokine production by LPS-stimulated (100 ng/mL) and
unstimulated BMDM from WKY, LEW and WLY/LCrgn1
congenic rats was assessed by a sandwich ELISA (BD
Biosciences, UK), according to the manufacturer’s in-
structions.23,24 Briefly, supernatants from BMDMs plated
in six-well plates at a density of 106 cells per well were
incubated in 2 mL of culture medium for 24 hours. The
supernatants were then added to the ELISA plate and
incubated at RT for 2 hours. Bound antibody was de-
tected by horseradish peroxidase–conjugated IgG, and
developed using the substrate 3,3=,5,5=-Tetramethylben-
zidine. The absorbencies for each well were read at 450
nm using an ELISA plate reader, and the results were
calculated as mean optical density for each triplicate
sample.
Inducible Nitric Oxide Synthase mRNA
Expression by Real-Time RT-PCR
The level of inducible nitric oxide synthase (iNOS)
mRNA expression by LPS-stimulated and nonstimu-
lated BMDM from WKY, LEW and WLY/LCrgn1 con-
genic rats was assessed by real-time RT-PCR, as pre-
viously described25,28 Briefly, total RNA was isolated
from BMDM using the trizol method. Real-time RT-PCR
was performed on an ABI 7500 Sequence Detection Sys-
tem (Applied Biosystems, Warrington, UK) using SYBR
Green (Stratagene, Cambridge, UK). A 200-ng quantity
of total RNA was used, and all of the samples were
amplified in triplicate. After the initial reverse transcription
(30 minutes at 50°C and 10 minutes at 95°C), the sam-
ples were cycled 40 times at 95°C for 30 seconds and
60°C for 45 seconds. Results were than exported to 7500
Fast system SDS software (ABS), and Ct values were
determined for iNOS and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The relative expression levels
were then determined by using the 2–Ct method.
Statistical Analysis
Differences between phenotypes in WKY, LEW, F1, BC1,
and congenic animals, and BMDM activation and func-
tion studies, were determined by the Mann-Whitney U
test. Analysis of variance was used to confirm differences
between multiple groups of animals. The correlation be-
tween quantitative phenotypic traits (percentage cres-
cents, number of glomerular macrophages, and albumin-
uria) in congenic animals was assessed by linear
regression. The associations between extreme pheno-
typic traits (BC1 animals with 20% crescent formation
versus those with no affected glomeruli) and polymorphic
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cies. Multipoint quantitative trait locus (QTL) analysis to
test for linkage between genetic markers and severity of
EAG was performed using the Mapmaker QTL pro-
gram.22
Results
Assessment of EAG in BC1 Animals
WKY rats immunized with rat GBM in FCA developed
high levels of albuminuria, a large glomerular infiltration of
macrophages, and severe focal necrotizing glomerulo-
nephritis with crescent formation, by day 28 after immu-
nization. By contrast, LEW rats immunized with the same
antigen showed no significant increase in the level of
albuminuria or glomerular macrophages and no histolog-
ical evidence of nephritis. BC1 animals developed a
range in severity of EAG from no histological evidence of
disease to severe crescentic glomerulonephritis. (Figure 1,
A–C). The distribution of disease was the same in the
Figure 1. Phenotypic characterization of WKY, LEW, and BC1 animals after
immunization with rat GBM, showing (A) crescents, (B) glomerular macro-
phages, and (C) albuminuria. Results shown represent the value for each animal
at day 28 after immunization. Correlation analysis of phenotypic characterization
of BC1 animals showing the correlation (D) between crescents and glomerular
macrophages and (E) between crescents and albuminuria.male and female backcross animals.There was a significant correlation between the per-
centage of glomerular crescents and the number of glo-
merular macrophages in individual BC1 animals (r2 
0.89, P  0.001). There was also a significant correlation
between the percentage of crescents and albuminuria
(r2  0.39, P  0.001). (Figure 1, D and E).
Genome-Wide Linkage Analysis of EAG
Phenotypes in BC1 Animals
Genome-wide linkage analysis for glomerular crescents
following EAG induction revealed a significant QTL on
chromosome 13 with a logarithm of the odds (LOD) score
of 3.9. The peak of linkage was located at the marker
D13Rat86 and the significant linkage was over an ap-
proximate length of 35 cM (Figure 2). This chromosomal
region comprises many candidate genes including the
Fc gamma receptor cluster. Importantly, this segment of
chromosome 13 was previously found to be linked to
glomerular crescents (LOD 8), proteinuria, and macro-
phage infiltration in the WKY NTN model (24). These
results suggest that both EAG and NTN models in the
WKY rat share common genetic architecture underlying
glomerular inflammation.
Assessment of EAG in Congenic Animals
WKY rats immunized with recombinant rat 3(IV)NC1 in
FCA developed circulating anti-3(IV)NC1 antibodies,
strong linear deposits of IgG on the GBM, high levels of
albuminuria, severe focal necrotizing glomerulonephritis
with crescent formation, and marked glomerular infiltra-
tion by macrophages, by day 28 after immunization. By
contrast, LEW rats immunized with the same antigen
were resistant to the development of EAG. WKY.LCrgn1
congenic rats showed a significant reduction in severity
of crescentic nephritis, number of glomerular macro-
phages, and albuminuria, when compared with WKY
controls (Figures 3 and 4). No reduction in the levels of
Figure 2. Logarithm of odds (LOD) score plot for glomerular crescents.
Genetic map of chromosome 13, based on data from 196 BC1rats, was
constructed using MAPMAKER/EXP version 3.0b. Positions of marker loci
genotyped are indicated on the x axis. LOD scores at each position of the
map were calculated using MAPMAKER/QTL version 1.9. The most likely
position of the QTL (EAG1), determined by its 1-LOD support interval, is
indicated by the solid black bar above the plot. Horizontal lines represent the
threshold for significance of the LOD score. Map distances are given in
centiMorgans (cM) determined with the Kosambi map function.
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LEW.WCrgn1 congenic rats were resistant to the devel-
opment of EAG, similar to LEW controls.
Assessment of Fc Receptor–Mediated Oxidative
Burst, Phagocytosis, and LPS-Induced MCP-1
Synthesis and iNOS Expression in
Macrophages of Congenic Rats
Bone marrow–derived macrophages (BMDM) from WKY
rats showed a significant increase in Fc receptor–medi-
ated oxidative burst, when compared with LEW rats.
BMDM from WKY.LCrgn1 congenic rats showed a signif-
icant reduction in Fc receptor mediated oxidation, when
compared with WKY controls (Figure 6A).
BMDM from WKY rats showed a significant increase in
phagocytosis of opsonized polystyrene beads, when
compared with LEW rats. BMDM from WKY.LCrgn1 con-
Figure 3. Phenotypic characterization of WKY, LEW, and reciprocal con-
genic animals for chromosome 13 QTL (Crgn1) after immunization with
recombinant 3(IV)NC1, showing (A) crescents, (B) glomerular macro-
phages, and (C) albuminuria. Results shown represent the value for each
animal at day 28 after immunization (*P  0.001; **P  0.008; ***P  0.002,
WKY versus WKY.LCrgn1 animals).genic rats showed a significant reduction in phagocytosisof opsonised polystyrene beads, when compared with
WKY controls (Figure 6B).
WKY BMDMs showed a significant increase in the LPS-
induced MCP-1 secretion and iNOS mRNA expression,
when compared with LEW rats, whereas WKY.LCrgn1
BMDMs showed a significant reduction in the LPS-in-
duced levels of MCP-1 and iNOS, when compared with
WKY controls (Figure 6, C and D).
Discussion
The WKY rat shows a marked susceptibility to crescentic
glomerulonephritis, both in the model of nephrotoxic ne-
phritis (NTN), which is induced by administration of a
heterologous antibody directed against the GBM,27 and
also in the model of experimental autoimmune glomeru-
lonephritis (EAG), which depends on immunization with
GBM or 3(IV)NC1.18–20 The EAG model therefore differs
from NTN in that it depends on the generation of an
immune response against the administered autoantigen.
It is important to appreciate that, although both of these
Figure 4. A: Hematoxylin and eosin stain of kidney sections at day 28 after
immunization with 3(IV)NC1, showing severe crescentic glomerulonephri-
tis in a WKY rat, normal glomerular architecture in a LEW rat, moderate
glomerular damage in a WKY.LCrgn1 congenic rat, and normal glomerular
architecture in a LEW.WCrgn1 congenic rat. Original magnification,200. B:
Immunoperoxidase stain of kidney sections at day 28 after immunization
with 3(IV)NC1, showing a large number of glomerular macrophages in a
WKY rat, a few glomerular macrophages in a LEW rat, a moderate number of
glomerular macrophages in a WKY.LCrgn1 congenic rat, and a few glomer-
ular macrophages in a LEW.WCrgn1 congenic rat.
n the GB
nic rat.
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the genetics are distinct; in the NTN model F1 animals
show intermediate susceptibility,24 whereas in the EAG
model F1 animals are completely resistant to disease.22
In EAG, BC1 animals, generated by crossing WKY with
F1 rats, showed a range of responses to immunization
with GBM, from severe crescentic glomerulonephritis to
no histological evidence of disease.22 In that study, we
also adopted a candidate gene approach to investigate
whether the gene for the autoantigen 3(IV)NC1
Figure 5. Phenotypic characterization of WKY, LEW, and reciprocal congen
antibodies and (B) deposited antibodies on the GBM. (C) Direct immunofluo
strong linear deposits of IgG on the GBM in a WKY rat, no deposits of IgG o
congenic rat, and no deposits of IgG on the GBM in a LEW.WCrgn1 conge
Figure 6. Analysis of Fc receptor–mediated macrophage activation and
function in WKY, LEW, and WKY.LCrgn1 congenic rats, showing (A) Fc
oxyburst assay, (B) bead phagocytosis assay, (C) MCP-1 production after
stimulation by LPS, and (D) iNOS mRNA expression after stimulation by LPS
Results shown represent the mean  SD for each group. (*P  0.02; **P 
0.001, WKY versus WKY.LCrgn1 congenic).(Col4a3), located on rat chromosome 9, was linked to the
development of EAG, but no significant linkage was de-
tected in the BC1 progeny.
It has previously been shown that differences in the
characteristics of the anti-GBM antibodies between WKY
and LEW rats account in part for the difference in sus-
ceptibility to EAG.23 This study demonstrated that anti-
GBM antibodies in WKY rats immunized with GBM were
present in a higher concentration and showed greater
specificity for 3(IV)NC1 when compared with antibodies
in LEW rats. In addition, passive transfer of eluted anti-
GBM antibodies from kidneys of WKY rats with EAG led to
similar deposition of IgG on the GBM of both WKY and
LEW rats, but resulted in the development of crescentic
glomerulonephritis only in WKY rats. These findings illus-
trate the importance of both the autoimmune response,
and also the inflammatory response to deposited anti-
body, in susceptibility to glomerulonephritis. In addition, it
has been demonstrated, using bone marrow and kidney
transplantation, that susceptibility to NTN in the WKY rat
depends on both circulating and intrinsic renal cells, and
that there are genetic differences between the strains in
mesangial cell responses to inflammatory stimuli.28
In the present study of the genetics of EAG, we bred,
immunized, and phenotyped a new cohort of BC1 ani-
mals (n  196), which showed a similar range in the
severity of nephritis to that previously reported.22 We
performed a genome-wide linkage analysis on this cohort
of animals using polymorphic microsatellite markers
spanning the whole of the rat genome. This revealed a
major quantitative trait locus (QTL) on chromosome 13
(LOD  3.9) linked to the severity of glomerulonephritis.
Several biological candidates are present in the region of
linkage, including genes encoding the Fc receptors
(FcR).
Because many forms of glomerulonephritis involve an-
tibody or immune complex localization in the kidney,
FcR are logical candidates for susceptibility, as they are
responsible for initiating a wide range of cellular re-
sponses when engaged by the Fc region of IgG. Several
FcR genes are located in the region of linkage on chro-
ls after immunization with recombinant 3(IV)NC1, showing (A) circulating
e of kidney sections at day 28 after immunization with 3(IV)NC1, showing
M in a LEW rat, strong linear deposits of IgG on the GBM in a WKY.LCrgn1ic anima
rescencmosome 13 in EAG, including genes encoding the acti-
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ceptor Fcgr2 (FcRII), and the common -subunit Fcer1g
(FcR). In parallel studies by our group, it was shown that
copy number polymorphism in Fcgr3 predisposes to the
development of NTN in the WKY rat, a related rat model
of glomerulonephritis.24 It therefore seems likely that
Fcgr3, or other FcR genes, account for the susceptibility
to EAG conferred by the chromosome 13 QTL.
To investigate the biological relevance of the QTL on
chromosome 13, congenic rats were generated by
transferring the chromosome 13 QTL region from WKY
rats to LEW (LEW.WCrgn1) and the same region from
LEW rats to WKY (WKY.LCrgn1).26 After immunization
with 3(IV)NC1, WKY.LCrgn1 congenic rats showed a
marked reduction in the severity of crescentic nephritis,
especially in those crescents affecting more than 50% of
the circumference of the glomerulus, and in the number
of glomerular macrophages, when compared with WKY
rats. This demonstrates that WKY.LCrgn1 congenic rats
develop a less severe form of crescentic nephritis than
WKY controls. Interestingly, there was no reduction in
anti-3(IV)NC1 antibody levels, suggesting that protec-
tion from disease in congenic rats is due to events down-
stream of or independent of antibody deposition. In ad-
dition, the protective effect of Crgn1 in EAG is more
pronounced than that seen in NTN,26 suggesting that
different susceptibility genes may be involved in these two
models of glomerulonephritis. By contrast, LEW.WCrgn1
congenic rats were completely resistant to the develop-
ment of EAG, as were LEW controls. Results from the
WKY.LCrgn1 animals demonstrate the importance of the
chromosome 13 QTL in the development of EAG,
whereas those from the LEW.WCrgn1 animals show that
other genes must be involved.
Because macrophage infiltration of the glomeruli is one
of the key features in the pathogenesis of EAG, we as-
sessed Fc receptor mediated macrophage activation
and function in WKY.LCrgn1 congenic rats. Bone mar-
row–derived macrophages (BMDM) from these animals
showed a significant reduction in Fc receptor–mediated
oxidation and phagocytosis of opsonized polystyrene
beads, and in the LPS-induced levels of MCP-1 secretion
and iNOS mRNA expression, when compared with
BMDM from WKY controls. This suggests that genetically
determined Fc receptor–mediated macrophage activa-
tion is particularly important in susceptibility to EAG.
However, it is known that other genes are involved in
macrophage activation. For example, we previously iden-
tified the AP-1 transcription factor Jund as a determinant
of macrophage activity in the second highly significant
QTL (Crgn2) in NTN. Jund transcription is markedly in-
creased in WKY BMDMs as compared with LEW, and
siRNA knockdown of JunD led to reduced Fc receptor–
dependent oxidative burst.25 We have recently gener-
ated double congenic rats for Crgn1 and Crgn2 from LEW
on a WKY genetic background, and confirmed the addi-
tive effect of both loci on macrophage infiltration and
activation in NTN.26
In conclusion, we have revealed a major QTL on rat
chromosome 13 linked to the percentage of glomerular
crescents in EAG. We have shown a reduction in theseverity of EAG and in Fc receptor-mediated macro-
phage activation in congenic rats in which the LEW chro-
mosome 13 congenic interval is introgressed onto the
WKY background. These results suggest that Crgn1, as
identified in NTN, is also involved in susceptibility to EAG.
The finding that the same genetic interval is involved in
two similar but genetically distinct models of glomerulo-
nephritis adds weight to its importance. These insights
into the susceptibility to experimental glomerulonephritis
may prove to be relevant to the immunopathogenesis of
human autoimmune glomerulonephritis.
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